Is ABVC Biopharma Inc halal to invest in?

According to Musaffa's Shariah screening methodology, ABVC Biopharma Inc (ABVC) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is ABVC Biopharma Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ABVC Biopharma Inc using these criteria to determine its compliance status.

Can Muslims buy shares of ABVC Biopharma Inc?

Muslim investors may consider investing in ABVC Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is ABVC Biopharma Inc classified as NOT HALAL?

Musaffa determines the Shariah status of ABVC Biopharma Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for ABVC Biopharma Inc updated?

The Shariah compliance status of ABVC Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like ABVC Biopharma Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of ABVC Biopharma Inc?

You can check the latest Shariah compliance status of ABVC Biopharma Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ABVC Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 05, 2026

Report Source: 2025 Annual Report

ABVC Biopharma Inc. Stock Analysis ABVC

United States Health Care Nano Cap Report: 2025 Annual

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The company is headquartered in Fremont, California and currently employs 19 full-time employees. The company went IPO on 2004-11-09. The firm is focused on the development of new drugs and medical devices, all of which are derived from plants. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV-1501, and ABV-1701. The firm is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine. ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). The company has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. The company has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer.

Key Statistics of ABVC Biopharma Inc (ABVC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.05$1.10

Today's Open

$1.08

Volume

68.61K

P/E Ratio (TTM)

52 Week Range

$0.88$5.48

Market Cap

26.20M

Avg. Volume

74.88K

Dividend Yield

Financial Metrics & Statements of ABVC Biopharma Inc (ABVC)

FAQ's for ABVC Biopharma Inc (ABVC)

According to Musaffa’s Shariah screening methodology, ABVC Biopharma Inc (ABVC) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.